【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Increasing incidences of chronic diseases
4.1.1.2 Technological advancements
4.1.1.3 Growing awareness levels
4.2 Market Restraint Analysis
4.2.1.1 High cost of therapeutic mAbs
4.3 Penetration & growth prospect mapping
4.4 Monoclonal Antibodies – SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis – Porter’s
Chapter 5 Market Categorization 1: Source Type Estimates & Trend Analysis
5.1 Monoclonal antibodies market: Source type movement analysis
5.2 Murine
5.2.1 Murine market, 2013 – 2024 (USD Billion)
5.3 Chimeric
5.3.1 Chimeric market, 2013 – 2024 (USD Billion)
5.4 Humanized
5.4.1 Humanized market, 2013 – 2024 (USD Billion)
5.5 Human
5.5.1.1 Human market, 2013 – 2024 (USD Billion)
Chapter 6 Market Categorization 2: Production Type Estimates & Trend Analysis
6.1 Monoclonal antibodies market: Production type movement analysis
6.2 In vitro
6.2.1 In vitro market, 2013 – 2024 (USD Billion)
6.3 In vivo
6.3.1 In vivo market, 2013 – 2024 (USD Billion)
Chapter 7 Market Categorization 3: Indication Estimates & Trend Analysis
7.1 Monoclonal antibodies market: Disease movement analysis
7.2 Cancer
7.2.1 Cancer Market, 2013 – 2024 (USD Billion)
7.3 Autoimmune diseases
7.3.1 Autoimmune diseases market, 2013 – 2024 (USD Billion)
7.4 Inflammatory diseases
7.4.1 Inflammatory diseases market, 2013 – 2024 (USD Billion)
7.5 Infectious diseases
7.5.1 Infectious diseases market, 2013 – 2024 (USD Billion)
7.6 Microbial diseases
7.6.1 Microbial diseases market, 2013 – 2024 (USD Billion)
7.7 Others
7.7.1 Others diseases market, 2013 – 2024 (USD Billion)
Chapter 8 Market Categorization 4: End-Use Estimates & Trend Analysis
8.1 Monoclonal antibodies market: End-use movement analysis
8.2 Hospitals
8.2.1 Hospitals market, 2013 – 2024 (USD Billion)
8.3 Research Institutes
8.3.1 Research institutes market, 2013 – 2024 (USD Billion)
8.4 Others
8.4.1 Others market, 2013 – 2024 (USD Billion)
Chapter 9 Market Categorization 5: Regional Estimates & Trend Analysis, by Source Type, Production Type, Indication & End-Use
9.1 Monoclonal antibodies market shares by region, 2015 & 2024
9.2 North America
9.2.1 North America Monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.2.2 U.S.
9.2.2.1 U.S. monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.2.3 Canada
9.2.3.1 Canada monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3 Europe
9.3.1.1 Europe monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3.2 Germany
9.3.2.1 Germany monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3.3 UK
9.3.3.1 UK monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4 Asia Pacific
9.4.1.1 Asia Pacific monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.2 Japan
9.4.2.1 Japan monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.3 China
9.4.3.1 China monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.4 India
9.4.4.1 India monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5 Latin America
9.5.1.1 Latin America monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5.2 Brazil
9.5.2.1 Brazil monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5.3 Mexico
9.5.3.1 Mexico monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.6 MEA
9.6.1.1 MEA monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.6.2 South Africa
9.6.2.1 South Africa Monoclonal antibodies market estimates and forecasts, 2013 – 2024
Chapter 10 Competitive Landscape
10.1 Strategy framework
10.2 Market participation categorization
10.3 Company Profiles
10.3.1 Novartis International
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 Pfizer
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 GlaxoSmithKline Plc
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 Amgen Inc.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 Merck & Co., Inc.
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 Daiichi Sankyo
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 Abbott Laboratories
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 AstraZeneca plc
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 Eli Lilly
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 Johnson & Johnson
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 Bayer AG
10.3.11.1 Company Overview
10.3.11.2 Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.4 Strategic Initiatives
10.3.12 Bristol Myers Squibb
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.4 Strategic Initiatives
10.3.13 F.Hoffman-La Roche Ltd.
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 Mylan N.V.
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.14.4 Strategic Initiatives
10.3.15 Biogen Idec Inc.
10.3.15.1 Company Overview
10.3.15.2 Financial Performance
10.3.15.3 Product Benchmarking
10.3.15.4 Strategic Initiatives
10.3.16 Thermo Fisher Scientific
10.3.16.1 Company Overview
10.3.16.2 Financial Performance
10.3.16.3 Product Benchmarking
10.3.16.4 Strategic Initiatives
10.3.17 Novo Nordisk
10.3.17.1 Company Overview
10.3.17.2 Financial Performance
10.3.17.3 Product Benchmarking
10.3.17.4 Strategic Initiatives
10.3.18 Sanofi
10.3.18.1 Company Overview
10.3.18.2 Financial Performance
10.3.18.3 Product Benchmarking
10.3.18.4 Strategic Initiatives
10.3.19 Genzyme
10.3.19.1 Company Overview
10.3.19.2 Financial Performance
10.3.19.3 Product Benchmarking
10.3.19.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：モノクローナル抗体（mAb）の世界市場分析：由来別（キメラ、マウス、ヒト化、ヒト）、生産タイプ別、指示別（がん、自己免疫性、炎症性、感染性、微生物性、ウイルス性疾患）、エンドユーザー別（病院、研究機関、学術機関、診療所、診断研究所）、セグメント予測、2013 – 2024■ 英文：Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use (Hospitals, Research, Academic Institutes, Clinics, Diagnostic Laboratories) And Segment Forecasts, 2013 - 2024
■ 発行日：2016年11月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707560
■ 調査対象地域：グローバル
- セーフティレーザースキャナーの世界市場予測（～2023年）“SAFETY LASER SCANNER MARKET TO GROW AT A HIGHER CAGR of 5.99% DURING 2018–2023”The overall safety laser scanner market is expected to grow from USD 304 million in 2018 to USD 406 million by 2023, at a high CAGR during the forecast period. Safety laser scanners offer long-term cost-effective solutions for use with new machine installations or for retrofitting machines, plants, or even vehicles. Th …
- 世界の商業用航空機ウインドウ＆ウインドシールド市場With the increase in global air travel, growth in Passengers investment appetite and to fight against the rising fuel prices, airlines are continuously improving and improvising to enhance their aircraft efficiency, luxury and comfort to the air travelers. An aircraft window is one of the key focus areas in this regards. Current commercial aviation fleet size is composed of 63% of NBAs, 19% of WBA …
- 民間無人機（ドローン）の世界市場：種類、技術、用途、地域別分析Commercial drones or commercial unmanned aerial vehicles (UAV) refer to small aircraft which fly without direct human control and are guided by a remote device. The incidents related to natural disaster and public unrest during recent times have necessitated the use of remote sensing and aerial surveillances. Hence, the UAVs have emerged as a viable alternative in such a scenario. They can capture …
- 骨固定型補聴器の世界市場2016-2020About Bone-anchored Hearing Aids Hearing aid amplifies the sound volume and improves sound perception to support people with hearing impairment but does not restore the normal functioning of the ear. The device has three basic components: microphone, amplifier, and speaker. The microphone of a hearing aid receives and converts sound waves into electrical signals. An amplifier increases the power o …
- 世界の軍用機MRO市場2015-2025Summary The global military aviation MRO market is expected to be driven by aging fleets of military aircraft and helicopters, technological innovations, internal and external security threats, territorial disputes, and modernization initiatives undertaken by governments around the world. Cumulatively, the market is projected to value US$558.7 billion during 2015-2025 and is expected to be dominat …
- M2Mソリューション：グローバル市場分析及び予測（M2M Solutions: Global Market Analysis and Forecasts 2012 – 2017）Machine-to-Machine (M2M) communication is a revolutionary technology that allows effective supervision and maintenance of physical assets. In recent years, M2M has become much more complex and “smart” due to major advances in semiconductor and software with the potential to be embedded in virtually any asset or object requiring monitoring and control throughout the enterprise. The expansion of M2M …
- 世界のモバイル端末用カメラモジュール市場：Global Camera Module in Mobile Device Market 2014-2018TechNavio's analysts forecast the Global Camera Module in Mobile Device market to grow at a CAGR of 13.20 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablets. The Global Camera Module in Mobile Device market has also been witnessing rapid advancement in technology. However, the high cost of production co …
- 急性心不全(Acute Heart Failure)の治療薬パイプライン動向（2015年上半期版）Acute Heart Failure - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H1 2015’, provides an overview of the Acute Heart Failure’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- インドのバイオ燃料市場分析：Analyzing the Indian Biofuel IndustryAlthough biofuels are mainly used to replace or supplement the traditional petroleum-based transportation fuels, they can also be deployed to generate heat and electricity. Being an alternative to fossils, biofuels can be applied to existing vehicles with little or no engine modification. Although they release CO2 when burned in internal combustion engines, they differ from fossil fuels partly bec …
- ドイツの気道装置・麻酔装置市場Germany Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Germany Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Germany Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Mas …
- ブラジル/ロシア/インド/中国における心臓補助装置の市場動向（～2020）BRIC Cardiac Assist Devices Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiac Assist Devices Market Outlook to 2020", provides key market data on the BRIC Cardiac Assist Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Intra-Aortic Balloon Pumps, Total Artificial Heart …
- Syphilis：医療検査市場2014The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comme …
- Heine Optotechnik GmbH & Co KG：市場シェア分析Heine Optotechnik GmbH & Co KG Market Share Analysis Summary GlobalData’s new report, “Heine Optotechnik GmbH & Co KG Market Share Analysis” provides in-depth information on Heine Optotechnik GmbH & Co KG’s market position in the ophthalmic diagnostic equipment market. The report also provides data and information on the overall competitive landscape within the ophthalmic diagnostic equipment mark …
- ソーラーパワーの技術分析：Analyzing Solar Power TechnologiesThe solar PV market has been booming over the last years and is forecasted to confirm this trend in the coming years. The harnessing of solar energy is not new in fact, development of solar energy dates back more than 100 years, to the middle of the industrial revolution. Solar energy is pollution-free, an important benefit when the cost of removing pollutants from the environment is considered. F …
- 世界の鎮痛剤（痛み止め）市場予測：麻薬性鎮痛薬/非麻酔鎮痛薬/神経因性疼痛薬/抗片頭痛薬/抗関節炎薬Pain relieving drugs - new study showing you trends, R&D progress, and predicted revenues Where is the pain relieving drugs market heading? What are the commercial prospects for this market and related technologies? See what the future holds for painkillers. Visiongain’s new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects. Our 323 page rep …
